<p>&#8220;On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will apply to drugs that administration officials determine promote &#8216;the health interests of Americans.&#8217; The initiative, referred to as the Commissioner&#8217;s National Priority Voucher program, allows drug developers to participate in a novel [&#8230;]</p> <p>The post <a href="https://humanprogress.org/fda-offers-speedier-approvals-to-select-drug-companies/">FDA Offers Speedier Approvals to Select Drug Companies</a> appeared first on <a href="https://humanprogress.org">Human Progress</a>.</p>